Abdul Rafae
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
- Hematology 15
- Multiple Myeloma Research and Treatments 10
- Chronic Myeloid Leukemia Treatments 2
- Genetics 6
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Ahsan Wahab (9 shared papers)Hamid Ehsan (9 shared papers)Faiz Anwer (15 shared papers)Kamran Mushtaq (3 shared papers)Seren Durer (3 shared papers)Ceren Durer (3 shared papers)Frits van Rhee (1 shared paper)Samer Al Hadidi (1 shared paper)
- Journals
- Blood (4 papers)Blood Reviews (2 papers)The Oncologist (1 paper)Frontiers in Oncology (1 paper)OncoTargets and Therapy (1 paper)
- Partner nations
- United StatesPakistanIndia
In The Last Decade
Abdul Rafae
26 papers receiving 294 citations
Peers
Comparison fields: 5 of 65
- Hematology 135
- Oncology 99
- Genetics 27
- Transplantation 5
- Radiology, Nuclear Medicine and Imaging 26
Countries citing papers authored by Abdul Rafae
This map shows the geographic impact of Abdul Rafae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul Rafae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul Rafae more than expected).
Fields of papers citing papers by Abdul Rafae
This network shows the impact of papers produced by Abdul Rafae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul Rafae. The network helps show where Abdul Rafae may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdul Rafae, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 65 | |
| 2 | 2020 | 44 | |
| 3 | 2019 | 43 | |
| 4 | 2018 | 23 | |
| 5 | 2023 | 23 | |
| 6 | 2015 | 18 | |
| 7 | 2022 | 14 | |
| 8 | 2022 | 13 | |
| 9 | 2019 | 8 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 5 | |
| 13 | 2019 | 4 | |
| 14 | 2022 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2020 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2020 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2020 | 2 |
About Abdul Rafae
Abdul Rafae is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 300 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Viral-associated cancers and disorders (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (135 citations), Oncology (99 citations), Genetics (27 citations), Transplantation (5 citations) and Radiology, Nuclear Medicine and Imaging (26 citations). Abdul Rafae has collaborated with scholars based in United States, Pakistan and India. Frequent co-authors include Ahsan Wahab, Hamid Ehsan, Faiz Anwer, Kamran Mushtaq, Seren Durer, Ceren Durer, Frits van Rhee, Samer Al Hadidi, Christy Joy Samaras and Ahmad Kamal. Their work appears in journals such as Blood, Blood Reviews, The Oncologist, Frontiers in Oncology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.